Updated on 2022/06/06

写真a

 
NISHIWAKI Hiroshi
 
Organization
Graduate School of Medicine Center for Research of Laboratory Animals and Medical Research Engineering Division for Advanced Medical Research Assistant Professor
Graduate School
Graduate School of Medicine
Undergraduate School
School of Medicine Department of Medicine
Title
Assistant Professor

Degree 1

  1. 博士(医学) ( 2021.3   名古屋大学 ) 

Research Areas 1

  1. Life Science / Hygiene and public health (laboratory)  / 腸内細菌、統計学、機械学習、ゲノム解析

 

Papers 8

  1. Meta-Analysis of Gut Dysbiosis in Parkinson's Disease Reviewed

    Hiroshi Nishiwaki MD,Mikako Ito PhD,Tomohiro Ishida MS,Tomonari Hamaguchi MD, PhD,Tetsuya Maeda MD, PhD,Kenichi Kashihara MD, PhD,Yoshio Tsuboi MD, PhD,Jun Ueyama PhD,Teppei Shimamura PhD,Hiroshi Mori PhD,Ken Kurokawa PhD,Masahisa Katsuno MD, PhD,Masaaki Hirayama MD, PhD,Kinji Ohno MD, PhD

    Movement Disorders     2020.6

     More details

    Authorship:Lead author  

    DOI: https://doi.org/10.1002/mds.28119

  2. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson's disease.

    Nishiwaki H, Ito M, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Yoshida T, Hanada H, Takeuchi I, Katsuno M, Hirayama M, Ohno K

    NPJ Parkinson's disease   Vol. 8 ( 1 ) page: 65   2022.6

     More details

    Language:English  

    DOI: 10.1038/s41531-022-00328-5

    PubMed

  3. Molecular Hydrogen Enhances Proliferation of Cancer Cells That Exhibit Potent Mitochondrial Unfolded Protein Response

    Hasegawa Tomoya, Ito Mikako, Hasegawa Satoru, Teranishi Masaki, Takeda Koki, Negishi Shuto, Nishiwaki Hiroshi, Takeda Jun-ichi, LeBaron Tyler W., Ohno Kinji

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES   Vol. 23 ( 5 )   2022.3

     More details

    Language:Japanese   Publisher:International Journal of Molecular Sciences  

    Molecular hydrogen ameliorates pathological states in a variety of human diseases, animal models, and cell models, but the effects of hydrogen on cancer have been rarely reported. In addition, the molecular mechanisms underlying the effects of hydrogen remain mostly unelucidated. We found that hydrogen enhances proliferation of four out of seven human cancer cell lines (the responders). The proliferation-promoting effects were not correlated with basal levels of cellular reactive oxygen species. Expression profiling of the seven cells showed that the responders have higher gene expression of mitochondrial electron transport chain (ETC) molecules than the non-responders. In addition, the responders have higher mitochondrial mass, higher mitochondrial superoxide, higher mitochondrial membrane potential, and higher mitochondrial spare respiratory capacity than the non-responders. In the responders, hydrogen provoked mitochondrial unfolded protein response (mtUPR). Suppression of cell proliferation by rotenone, an inhibitor of mitochondrial ETC complex I, was rescued by hydrogen in the responders. Hydrogen triggers mtUPR and induces cell proliferation in cancer cells that have high basal and spare mitochondrial ETC activities.

    DOI: 10.3390/ijms23052888

    Web of Science

    Scopus

    PubMed

  4. Altered gut microbiota in Parkinson's disease patients with motor complications

    Takahashi Kai, Nishiwaki Hiroshi, Ito Mikako, Iwaoka Kazuhiro, Takahashi Kenta, Suzuki Yoshio, Taguchi Keita, Yamahara Kanako, Tsuboi Yoshio, Kashihara Kenichi, Hirayama Masaaki, Ohno Kinji, Maeda Tetsuya

    PARKINSONISM & RELATED DISORDERS   Vol. 95   page: 11 - 17   2022.2

     More details

    Language:Japanese   Publisher:Parkinsonism and Related Disorders  

    Introduction: Parkinson's disease (PD) is associated with gut dysbiosis. However, whether gut dysbiosis can cause motor complications is unclear. Methods: Subjects were enrolled from four independent movement disorder centers in Japan. We performed 16S ribosomal RNA gene sequence analysis of gut microbiota. Relative abundance of gut microbiota and relationships between them and clinical characteristics were statistically analyzed. Analysis of co-variance (ANCOVA) was used to assess altered gut microbiota associated with wearing-off or dyskinesia. Results: We enrolled 223 patients with PD. Wearing-off was noted in 47.5% of patients and dyskinesia in 21.9%. We detected 98 genera of bacteria. Some changes in the gut microbiota were observed in patients with PD and motor complications. After Bonferroni correction, patients with wearing-off showed decreased relative abundance of Lachnospiraceae Blautia (p < 0.0001) and increased relative abundance of Lactobacillaceae Lactobacillus (p < 0.0001), but patients with dyskinesia no longer showed significant changes in the gut microbiota. Adjustment with two models of confounding factors followed by ANCOVA revealed that age (p < 0.0001), disease duration (p = 0.01), and wearing-off (p = 0.0004) were independent risks for the decreased relative abundance of Lachnospiraceae Blautia, and wearing-off (p = 0.009) was the only independent risk factor for the increased relative abundance of Lachnospiraceae Lactobacillus. Conclusion: Relative abundance of Lachnospiraceae Blautia and Lactobacillaceae Lactobacillus was significantly decreased and increased, respectively, in the gut microbiota of PD patients with motor complications. This indicates that an altered gut microbiota is associated with the development of motor complications in patients with advanced PD.

    DOI: 10.1016/j.parkreldis.2021.12.012

    Web of Science

    Scopus

    PubMed

  5. Intestinal Collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate

    Hirayama Masaaki, Nishiwaki Hiroshi, Hamaguchi Tomonari, Ito Mikako, Ueyama Jun, Maeda Tetsuya, Kashihara Kenichi, Tsuboi Yoshio, Ohno Kinji

    PLOS ONE   Vol. 16 ( 11 ) page: e0260451   2021.11

     More details

    Language:Japanese   Publisher:PLoS ONE  

    The mortality rates of COVID-19 vary widely across countries, but the underlying mechanisms remain unelucidated. We aimed at the elucidation of relationship between gut microbiota and the mortality rates of COVID-19 across countries. Raw sequencing data of 16S rRNA V3-V5 regions of gut microbiota in 953 healthy subjects in ten countries were obtained from the public database. We made a generalized linear model (GLM) to predict the COVID- 19 mortality rates using gut microbiota. GLM revealed that low genus Collinsella predicted high COVID-19 mortality rates with a markedly low p-value. Unsupervised clustering of gut microbiota in 953 subjects yielded five enterotypes. The mortality rates were increased from enterotypes 1 to 5, whereas the abundances of Collinsella were decreased from enterotypes 1 to 5 except for enterotype 2. Collinsella produces ursodeoxycholate. Ursodeoxycholate was previously reported to inhibit binding of SARS-CoV-2 to angiotensin-converting enzyme 2; suppress pro-inflammatory cytokines like TNF-α, IL-1β, IL-2, IL-4, and IL-6; have antioxidant and anti-apoptotic effects; and increase alveolar fluid clearance in acute respiratory distress syndrome. Ursodeoxycholate produced by Collinsella may prevent COVID-19 infection and ameliorate acute respiratory distress syndrome in COVID-19 by suppressing cytokine storm syndrome.

    DOI: 10.1371/journal.pone.0260451

    Web of Science

    Scopus

    PubMed

  6. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder Reviewed

    Hiroshi Nishiwaki 1, Tomonari Hamaguchi 1, Mikako Ito 1, Tomohiro Ishida 2, Tetsuya Maeda 3, Kenichi Kashihara 4, Yoshio Tsuboi 5, Jun Ueyama 2, Teppei Shimamura 6, Hiroshi Mori 7, Ken Kurokawa 7, Masahisa Katsuno 8, Masaaki Hirayama 9, Kinji Ohno

    mSystems     2020.12

     More details

    Authorship:Lead author  

  7. Molecular hydrogen upregulates heat shock response and collagen biosynthesis, and downregulates cell cycles: meta-analyses of gene expression profiles Reviewed

    Hiroshi Nishiwaki 1, Mikako Ito 1, Shuto Negishi 1, Sayaka Sobue 2, Masatoshi Ichihara 2, Kinji Ohno 1

    Free Radical Research     2018.3

     More details

    Authorship:Lead author  

    DOI: 10.1080/10715762.2018.1439166

  8. Mechanism of Anomalous Tunneling in Condensed Bose System Reviewed

    Yusuke Kato, Hiroshi Nishiwaki, and Akitake Fujita

    J. Phys. Soc. Jpn.     2007.11

▼display all

Presentations 5

  1. GUT MICROBIOTA PREDICTS THE PROGRESSION OF EARLY PARKINSON'S DISEASE International conference

    Hiroshi Nishiwaki

    Targeting Microbiota 2021  2021.10.21 

     More details

    Event date: 2021.10

    Language:English   Presentation type:Poster presentation  

  2. Cross-platform-analysis and meta-analysis of gene expression profiles reveal pathways modulated by molecular hydrogen

    Hiroshi Nishiwaki

    2017.10.29 

     More details

    Event date: 2017.10

  3. Meta-analysis of gene expression profiles for dissecting molecular mechanisms of hydrogen

    Hiroshi Nishiwaki

    2016.5.26 

     More details

    Event date: 2016.5

    Language:Japanese  

  4. Gut microbiota in patients with Parkinson’s disease (PD) predicts disease progression better than clinical features International conference

    Hiroshi Nishiwaki

    The MDS Virtual Congress 2021  2021.9 

     More details

    Language:English   Presentation type:Poster presentation  

  5. Meta-analysis of gut dysbiosis in Parkinson's disease and prognostic factors

    Hiroshi Nishiwaki

    2020.6 

KAKENHI (Grants-in-Aid for Scientific Research) 1

  1. 腸内細菌叢を用いた機械学習によるパーキンソン病の予後予測

    Grant number:22K17343  2022.4 - 2024.3

    科学研究費助成事業  若手研究

    西脇 寛

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

Industrial property rights 1

  1. 腸内細菌叢に占めるコリンセラ属の情報を提供する方法、当該情報を用いたCOVID−19重症化予測方法およびサイトカインストーム重症化予測方

     More details

    Application no:2021-120143・C20210138JP#P01  Date applied:2021.7